CClinicalTrials.gg
Not yet recruitingNCT07714343Updated Jul 20, 2026

Recover@Home Postoperative Follow-up Study

An interventional study of Recovery@home in Hernia, Inguinal, Hernia, Femoral and Hernia, Umbilical, sponsored by Icahn School of Medicine at Mount Sinai. Not yet recruiting at 4 sites in Uganda. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
194
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This proposal describes a human subjects research study evaluating mHealth Ambulatory Surgery with Follow-up Nurse (Recovery@Home), as an alternative postoperative care pathway for selected low-acuity surgical procedures in Uganda. The Recovery@Home model discharges eligible patients home on the day of surgery and provides structured postoperative follow-up through nurse telephone calls, home visits, mobile-app documentation, escalation algorithms, and surgeon teleconsultation when clinically indicated. The proposed research includes a design to evaluate Recovery@Home against traditional postoperative inpatient care in a randomized controlled trial across three participating Ugandan surgical facilities.

Read the detailed description

Surgeries in high-income countries have progressively transitioned to ambulatory settings, but in low- and middle-income countries, even patients who have low-acuity surgeries still typically stay in the hospital after their surgeries, and these postoperative inpatient stays are costly and inefficient, for both patients and the surgical facilities. We propose an innovative approach of Recover@Home in Uganda, incorporating mobile technology into postoperative care, to ensure safe, cost-effective and efficient care with same-day discharge and reliable follow-up after surgery. Using a multicenter, randomized controlled trial, we will provide the evidence necessary to shift practice towards ambulatory surgery for low-acuity surgical procedures, resulting in more efficient and effective allocation of healthcare resources in LMICs.

02

Conditions studied

  • Hernia, Inguinal
  • Hernia, Femoral
  • Hernia, Umbilical
  • Hernia, Ventral
  • Thyroidectomy
  • Appendectomy
  • Testicular Hydrocele
  • Varicocele

Keywords

  • ambulatory surgery
  • nurse-led mobile health
  • postoperative care delivery
  • rural surgical facility
  • recovery at home
  • implementation science
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 years or older.
  • Undergoing one of the eligible surgical procedures: inguinal/femoral hernia repair; umbilical/epigastric hernia repair; excision of soft tissue tumors; thyroidectomy; or appendectomy; varicocelectomy, hydrocelectomy.
  • Able to provide informed consent, with consent read aloud and/or fingerprint signature permitted where approved by local ethics authorities.
  • Available for inpatient interviews, postoperative clinic visit interviews, and postoperative telephone and/or home follow-up during the 30-day postoperative period.

Exclusion criteria

Exclusion criteria:

  • Clinical determination by the surgeon or anesthesia team that same-day discharge is unsafe or inappropriate.
  • Inability to provide informed consent or lack of an approved surrogate/alternative consent process if required by the IRB.
  • Any other exclusion required by the final approved protocol or local regulatory authority.
  • ASA 3 or higher
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
194 participants (estimated)

Study arms

  • Experimental
    Intervention arm: Recovery@Home pathway

    Discharged early and followed through a structured, nurse-led home-based care pathway supported by mobile health tools.

    Other: Recovery@home

  • No intervention
    Traditional inpatient postoperative care

    Remain admitted for routine postoperative monitoring.

Interventions

  • OtherRecovery@home

    The Recovery@Home model discharges eligible patients home on the day of surgery and provides structured postoperative follow-up through nurse telephone calls, home visits, mobile-app documentation, escalation algorithms, and surgeon teleconsultation when clinically indicated.

05

What researchers measure

Primary outcomes

  1. Occurrence of any postoperative complication within 30 days

    Occurrence of any postoperative complication within 30 days-will be treated as a binary variable (1 = complication, 0 = no complication).

    Time frame: postoperative day 1, postoperative day 3, postoperative day 7, postoperative day 10, postoperative day 14, postoperative day 30

Secondary outcomes

  1. Financial cost to the patient

    Indirect and direct costs to the patient

    Time frame: end of study, at one month

  2. Facility cost

    facility costs includes building maintenance cost, personnel cost, material/equipment cost

    Time frame: end of study, at one month

06

Study locations

4 sites
  • Kyabirwa Surgical Center
    Jinja, Uganda, Uganda
  • Hope and Healing Center
    Iganga, Uganda
    • Isaac Mubezi · Principal investigator
  • Lubaga Hospital
    Kampala, Uganda
    • Julius Luyimbaazi · Principal investigator
  • Mengo Hospital
    Kampala, Uganda
07

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol, Sap, Icf, Csr

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07714343
Lead sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
University of Pittsburgh, Global Surgical Initiatives Kyabirwa Surgical Center, Fogarty International Center of the National Institute of Health
Responsible party
Linda P Zhang (Professor, Department of Surgery, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Jul 20, 2026
Start date
Mar 1, 2027 (estimated)
Primary completion
Nov 30, 2029 (estimated)
Completion
Nov 30, 2029 (estimated)
Last update
Jul 20, 2026

Study contacts

Linda P Zhang, MD
Contact
linda.zhang@mountsinai.org
(212) 241-0134
Linda P Zhang, MD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion